1992
DOI: 10.1016/0140-6736(92)91744-s
|View full text |Cite
|
Sign up to set email alerts
|

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
93
1
1

Year Published

1998
1998
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 178 publications
(95 citation statements)
references
References 7 publications
0
93
1
1
Order By: Relevance
“…Examples include nicotinic acid and glucocorticoids (77,78). Patients receiving ␣-interferon have been reported to develop diabetes associated with islet cell antibodies and, in certain instances, severe insulin deficiency (83,84). The list shown in Table 1 is not all-inclusive, but reflects the more commonly recognized drug-, hormone-, or toxin-induced forms of diabetes.…”
Section: Drug-or Chemical-induced Diabetesmentioning
confidence: 99%
“…Examples include nicotinic acid and glucocorticoids (77,78). Patients receiving ␣-interferon have been reported to develop diabetes associated with islet cell antibodies and, in certain instances, severe insulin deficiency (83,84). The list shown in Table 1 is not all-inclusive, but reflects the more commonly recognized drug-, hormone-, or toxin-induced forms of diabetes.…”
Section: Drug-or Chemical-induced Diabetesmentioning
confidence: 99%
“…Since IFN was first reported to be effective for HCV infection in 1986 (8), IFN has been widely used for patients with chronic hepatitis C. However, autoimmune diseases, such as autoimmune thyroiditis (9), rheumatoid arthritis (10), autoimmune hepatitis (11), systemic lupus erythematosus (12) and T1D (13) (14,15) and the present patient is likely such a case.…”
Section: Discussionmentioning
confidence: 85%
“…In 1992, it was documented for the first time that IFN therapy for chronic hepatitis C can induce T1D (13), and this was followed by similar case reports (reviewed in (19) (22,23). RBV administration should be avoided in patients with T1D-susceptible HLA.…”
Section: T1d Is At Least In Part An Autoimmune Disease Character-izedmentioning
confidence: 99%
“…This case is similar to our case in that the GAD antibody titer increased suddenly and extremely, but our case was not positive for thyroid autoantibodies and showed no abnormalities in an ultrasound examination of the thyroid, suggesting she did not have AITD. It has been reported that GAD antibody titers increase after emerging acute pancreatitis [14] or interferon use [15], but neither serum pancreatic enzyme, abdominal ultrasound examination, nor pancreatic magnetic resonance imaging showed any abnormalities, and interferon was not prescribed in our case.…”
Section: Case Reportmentioning
confidence: 84%